País: Nova Zelanda
Idioma: anglès
Font: Medsafe (Medicines Safety Authority)
Colestyramine 0.851 g/g (4g anhd cholestyramine resin / 4.7g Questran Lite powder);
Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics
Colestyramine 0.851 g/g (4g anhd cholestyramine resin / 4.7g questran light powder)
4.7 g
Powder for oral suspension
Active: Colestyramine 0.851 g/g (4g anhd cholestyramine resin / 4.7g Questran Lite powder) Excipient: Aspartame Citric acid Colloidal silicon dioxide Orange flavour 059107 AGEP0551 Propylene glycol alginate Xanthan gum
Sachet, 50 x 4.7g sachets, 60 dose units
Prescription
Prescription
sanofi-aventis SpA
Reduction of serum cholesterol levels and prevention of coronary heart disease. QUESTRAN is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoproteins). QUESTRAN LITE may be useful to lower elevated cholesterol that occurs in patients with combined hypercholesterolemia and hypertriglyceridemia, but it is not indicated where hypertriglyceridemia is the abnormality of most concern.
Package - Contents - Shelf Life: Sachet, 4.7g sachets - 50 dose units - 36 months from date of manufacture stored at or below 30°C
1991-10-24
1 NEW ZEALAND CONSUMER MEDICINE INFORMATION _ _ QUESTRAN® LITE _cholestyramine resin _ _ _ _ _ WHAT IS IN THIS LEAFLET _ _ This leaflet answers some common questions about QUESTRAN LITE. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking QUESTRAN LITE against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. _ _ _ _ WHAT QUESTRAN LITE IS USED FOR _ _ QUESTRAN LITE is used to reduce high levels of cholesterol in the blood & the prevention of coronary heart disease. The relief of pruritis (itching) associated with the flow of bile being partially blocked. The relief of diarrhoea caused by surgery or disease of the small bowel. QUESTRAN LITE contains cholestyramine (KOL-es-TIE- rameen) which belong to a group of medicines called resins. It reduces the level of cholesterol in the blood by combining with bile in the small intestine to form an insoluble complex, which is then excreted in faeces. The reduction of blood cholesterol levels help to prevent blockages in the blood vessels to the heart which reduces the likelihood of angina (chest pain with heart disease) & heart attacks QUESTRAN LITE may be used alone or in combination with other medicines. Your doctor will inform you if this is necessary. Your doctor may have prescribed QUESTRAN LITE for another reason. Ask your doctor if you have any questions about why QUESTRAN LITE was prescribed for you. There is no evidence that QUESTRAN LITE is addictive. This medicine is only available with a doctor’s prescription. The safety & effectiveness of using QUESTRAN LITE i Llegiu el document complet
NEW ZEALAND DATA SHEET 1. QUESTRAN LITE Cholestyramine resin for Oral Suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Aspartame Formulation. QUESTRAN LITE is a sugar free formulation containing 4g of cholestyramine per 4.7g of QUESTRAN LITE powder. Cholestyramine is the chloride salt of a basic anion exchange resin. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Powder for oral suspension. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Reduction of serum cholesterol levels and prevention of coronary heart disease. QUESTRAN is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoproteins). QUESTRAN LITE may be useful to lower elevated cholesterol that occurs in patients with combined hypercholesterolemia and hypertriglyceridemia, but it is not indicated where hypertriglyceridemia is the abnormality of most concern. Relief of pruritus associated with partial biliary obstruction. Patients with primary biliary cirrhosis may exhibit elevated serum cholesterol as part of their disease. When cholestyramine is used to treat the pruritus of partial biliary obstruction, it may lower serum cholesterol levels, produce no change, or cause rapid escape from a temporary lowering to pretreatment levels or rebound. Relief of diarrhoea following ileal resection or ileal disease (cholerrhoeic enteropathy). 4.2 DOSAGE AND METHOD OF ADMINISTRATION_ _ ADULTS: Usual maintenance therapy: 12 to 16g of cholestyramine resin equivalent to 14.1 to 18.8g QUESTRAN LITE per day (without regard to meals), is usually effective. CHILDREN: Dosage in infants and children has not been established. Begin therapy with small doses. Subsequent adjustment should be made according to clinical response or laboratory results and the benefit/risk ratio. USE IN CHOLESTEROL LOWERING: Define the type of hyperlipoproteinaemia. A trial of diet, weight reduction, etc., should be undertaken before therapy with QUESTRAN LITE Llegiu el document complet